To include your compound in the COVID-19 Resource Center, submit it here.

Blood-based test analyzes cfDNA, protein biomarkers for earlier cancer detection

In a study published in Science, researchers from Johns Hopkins University describe the development of CancerSEEK, a diagnostic that could enable earlier blood-based cancer detection by analyzing both cell-free DNA (cfDNA)

Read the full 313 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers